Ovarian cancer
Top Cited Papers
- 1 October 2014
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 384 (9951), 1376-1388
- https://doi.org/10.1016/s0140-6736(13)62146-7
Abstract
No abstract availableThis publication has 121 references indexed in Scilit:
- Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trialThe Lancet Oncology, 2013
- Ovarian cancer and smoking: individual participant meta-analysis including 28 114 women with ovarian cancer from 51 epidemiological studiesThe Lancet Oncology, 2012
- A binary histologic grading system for ovarian serous carcinoma is an independent prognostic factor: A population-based study of 4317 women diagnosed in Denmark 1978–2006Gynecologic Oncology, 2012
- Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studiesThe Lancet Oncology, 2012
- Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial ovarian and primary peritoneal malignancies: A Gynecologic Oncology Group studyGynecologic Oncology, 2011
- Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European Prospective Investigation into Cancer and NutritionBritish Journal of Cancer, 2011
- Integrated genomic analyses of ovarian carcinomaNature, 2011
- Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovaryThe Journal of Pathology, 2010
- Extended weekly dose-dense paclitaxel/carboplatin is feasible and active in heavily pre-treated platinum-resistant recurrent ovarian cancerBritish Journal of Cancer, 2009
- Frequency of Symptoms of Ovarian Cancer in Women Presenting to Primary Care ClinicsJAMA, 2004